Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 10
2003 8
2004 5
2005 4
2006 8
2007 3
2008 2
2012 1
2013 3
2018 2
2019 1
2022 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for keisuke hamasaki
Search for Kisuke Hamasaki instead (1 results)
[Hepatitis B].
Hamasaki K, Nakata K. Hamasaki K, et al. Nihon Rinsho. 2002 Jan;60 Suppl 1:209-12. Nihon Rinsho. 2002. PMID: 11838116 Review. Japanese. No abstract available.
Cell-penetrating mechanism of intracellular targeting albumin: Contribution of macropinocytosis induction and endosomal escape.
Ichimizu S, Watanabe H, Maeda H, Hamasaki K, Ikegami K, Chuang VTG, Kinoshita R, Nishida K, Shimizu T, Ishima Y, Ishida T, Seki T, Katsuki H, Futaki S, Otagiri M, Maruyama T. Ichimizu S, et al. Among authors: hamasaki k. J Control Release. 2019 Jun 28;304:156-163. doi: 10.1016/j.jconrel.2019.05.015. Epub 2019 May 10. J Control Release. 2019. PMID: 31082432
Design and tuning of a cell-penetrating albumin derivative as a versatile nanovehicle for intracellular drug delivery.
Ichimizu S, Watanabe H, Maeda H, Hamasaki K, Nakamura Y, Chuang VTG, Kinoshita R, Nishida K, Tanaka R, Enoki Y, Ishima Y, Kuniyasu A, Kobashigawa Y, Morioka H, Futaki S, Otagiri M, Maruyama T. Ichimizu S, et al. Among authors: hamasaki k. J Control Release. 2018 May 10;277:23-34. doi: 10.1016/j.jconrel.2018.02.037. Epub 2018 Mar 10. J Control Release. 2018. PMID: 29530390
Development of Kupffer cell targeting type-I interferon for the treatment of hepatitis via inducing anti-inflammatory and immunomodulatory actions.
Minayoshi Y, Maeda H, Yanagisawa H, Hamasaki K, Mizuta Y, Nishida K, Kinoshita R, Enoki Y, Imafuku T, Chuang VTG, Koga T, Fujiwara Y, Takeya M, Sonoda K, Wakayama T, Taguchi K, Ishima Y, Ishida T, Iwakiri Y, Tanaka M, Sasaki Y, Watanabe H, Otagiri M, Maruyama T. Minayoshi Y, et al. Among authors: hamasaki k. Drug Deliv. 2018 Nov;25(1):1067-1077. doi: 10.1080/10717544.2018.1464083. Drug Deliv. 2018. PMID: 29688069 Free PMC article.
Frequency of elevated biomarkers in patients with cryptogenic hepatocellular carcinoma.
Taura N, Ichikawa T, Miyaaki H, Ozawa E, Tsutsumi T, Tsuruta S, Kato Y, Goto T, Kinoshita N, Fukushima M, Kato H, Ohata K, Ohba K, Masuda J, Hamasaki K, Yatsuhashi H, Nakao K. Taura N, et al. Among authors: hamasaki k. Med Sci Monit. 2013 Sep 6;19:742-50. doi: 10.12659/MSM.889361. Med Sci Monit. 2013. PMID: 24008520 Free PMC article.
49 results